BioStat International Announces Launch of rED Cap 2.0
rED CapTM 2.0 will provide users with enhanced features as well as new capabilities. Sponsors can now use rED CapTM to manage device inventory and accountability and have data from external sources imported directly to eCRF for viewing and reporting. Monitors have new tools for messaging study coordinators on outstanding tasks and sharing documents directly with project managers.
“We had an extremely successful launch of rED Cap 1.0 last fall at BioFlorida,” said Maureen Lyden, president of BSI. “Since then, we’ve garnered valuable feedback from our clients on how to enhance user experience.”
Additionally, rED CapTM 2.0 will allow the eCRF developer to control entry and viewing, data validation, and to integrate messaging to team members based on data entered into the eCRF. Other features designed to make the software more intuitive and user friendly include locations of tools and hyper-linking between query management and eCRF.
For more information about BSI, please visit www.biostatinc.com or to inquire about its services or for a demonstration of rED Cap Software, please contact Maureen Lyden at 813-979-1619 or mlyden@biostatinc.com
About BioStat International, Inc.
Biostat International, Inc., is a contract research organization designed to meet the needs of device and pharmaceutical companies by providing a full range of product development services. Since its founding in 1994, BSI has delivered quality biostatistical and data management services and has expanded into project management, clinical monitoring, and medical writing. Its sincere devotion to quality, personal attention, support and commitment has made BSI a client-favorite CRO.
Media Contact: Darlene Rotch - Panorama Public Relations - darlene@prview.com 205-531- 5181